Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Allergan PLC (AGN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Allergan's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Allergan historical data, for real-time data please try another search
193.02 0.00    0.00%
15:59:59 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 191.64 - 193.38
Allergan 193.02 0.00 0.00%

AGN Cash Flow Statement

 
Featured here, the Cash Flow Statement for Allergan PLC, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Collapse All
Period Ending: 2020
31/03
 2019
31/12
 2019
30/09
 2019
30/06
Period Length: 3 Months 12 Months 9 Months 6 Months
Net Income/Starting Line 379 -5265.1 -4947.8 -4162.2
Cash From Operating Activities 116.5 7238.7 5568.4 2644.3
Depreciation/Depletion 56.8 204.5 150.6 96.2
Amortization 1416.4 5856.6 4339.1 2801.4
Deferred Taxes -1931.1 -660.9 -365.3 -166.4
Non-Cash Items 1272.9 5000.7 4558.7 4413
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 68.7 876.5 1019.8 450.9
Cash Interest Paid 237.6 784.9 642.2 401.1
Changes in Working Capital -1077.5 2102.9 1833.1 -337.7
Cash From Investing Activities 1679.1 -2858.8 -2632.7 462.6
Capital Expenditures -118 -433.5 -299.3 -198.3
Other Investing Cash Flow Items, Total 1797.1 -2425.3 -2333.4 660.9
Cash From Financing Activities -3268.4 -2766.1 -2568.6 -2338.6
Financing Cash Flow Items -2.8 -9.3 -6.3 -4.1
Total Cash Dividends Paid -243.5 -974.4 -731.4 -488.8
Issuance (Retirement) of Stock, Net 9.7 -749.4 -789.3 -809.9
Issuance (Retirement) of Debt, Net -3031.8 -1033 -1041.6 -1035.8
Foreign Exchange Effects -31 9.1 -10 2.7
Net Change in Cash -1503.8 1622.9 357.1 771
Beginning Cash Balance - 880.4 880.4 880.4
Ending Cash Balance - 2503.3 1237.5 1651.4
Free Cash Flow - 6805.2 5269.1 2446
Free Cash Flow Growth - - - -
Free Cash Flow Yield - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

AGN Comments

Write your thoughts about Allergan PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Cornell
TheeAlmighty Jul 23, 2019 7:08PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I have been watching this since before the merger news broke. and the way it has been acting and the large "dark pool" orders and the fat fingers down its acting the same way...there will be more news soon. idk what it may be another company with a bigger offer or something...I know theyll probably beat eps. and they have declared a .74 cent dividend . they also have new drugs available in the US and new trials starting . would not be surprised to see another buyout off of 200 ps or even higher.
Reply
0 2
Report
Jeff Bailey
JeffB Jul 23, 2019 7:08PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I would be very surprised if another buyout offer came in. As for anti-trust issues, I don't see that either. No overlapping drugs. The Democrats that want to block the merger, just dislike pharma company's and this merger is a way for some of the presidential candidates to get some airtime and try to convince Ameticans this merger is a way for bug pharma to get more leverage, when all it really is, is a cost savings initiative to combine and eliminate some duplication.
Reply
0 0
Report
Mike Cornell
TheeAlmighty Jul 22, 2019 6:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
news will come soon of a potential better offer. price is acting same as it was before...just wait ...
Reply
0 1
Report
John Perry
JP3000 Jul 01, 2019 12:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Really, really odd that this is down. There must be doubts about this going through.
Reply
0 0
Report
Matt Harbison
Matt Harbison Jun 26, 2019 11:23AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Shooting to 188$
Reply
0 1
Report
Jeff Bailey
JeffB Jun 26, 2019 11:23AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Not sure another bidder will come to the table. If PFE hadn't just paid cash for ARRY, they might have come to the party here.
Reply
0 0
Report
Ned Stark
Ned Stark Jun 26, 2019 11:23AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
oh yea put some more of my out of the money call options $30 in the money!!!
Reply
0 1
Report
Jeff Bailey
JeffB Jun 25, 2019 12:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
AGN $164.00 +26.57%
Reply
2 0
Report
Maxim Tsygankov
Maxim Tsygankov Jun 25, 2019 8:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
170$
Reply
2 0
Report
John Perry
JP3000 Jun 25, 2019 8:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Actually will get to 188 since that is the selling price. not sure why you're hung on 170.
Reply
1 0
Report
Clinton Hansen
Clinton Hansen Jun 25, 2019 8:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
John Perry  The deal is not for sure! It is scheduled for early 2020. So many of these deals do not happen. You should read the buyout more carefully. It states a 120 per share with a .81 ABBV per share add. .81 * ABBV current price per share 67.8 = 174.91. That is your best case scenario. What happens when ABBV drops to $50 before the deal. Now your looking at $160 a share.
Reply
0 0
Report
Csaba Kiss
Csaba Kiss May 01, 2019 9:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
155671786796842.jpg
Triangle?
Reply
2 0
Report
Bade Sahib
Bade Sahib Mar 26, 2019 12:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Law suits are coming on their breast implants that have caused cancer
Reply
0 1
Report
John Perry
JP3000 Mar 17, 2019 10:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Potential buyout candidate. But probably not worth the downside risk.
Reply
0 0
Report
Jeff Bailey
JeffB Mar 07, 2019 3:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$143
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email